[go: up one dir, main page]

AU4135600A - Prostate cancer associated human fibronectin gene and biallelic markers - Google Patents

Prostate cancer associated human fibronectin gene and biallelic markers

Info

Publication number
AU4135600A
AU4135600A AU41356/00A AU4135600A AU4135600A AU 4135600 A AU4135600 A AU 4135600A AU 41356/00 A AU41356/00 A AU 41356/00A AU 4135600 A AU4135600 A AU 4135600A AU 4135600 A AU4135600 A AU 4135600A
Authority
AU
Australia
Prior art keywords
prostate cancer
cancer associated
biallelic markers
human fibronectin
associated human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41356/00A
Inventor
Marta Blumenfeld
Lydie Bougueleret
Ilya Chumakov
Annick Cohen-Akenine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of AU4135600A publication Critical patent/AU4135600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU41356/00A 1999-03-29 2000-03-28 Prostate cancer associated human fibronectin gene and biallelic markers Abandoned AU4135600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12678099P 1999-03-29 1999-03-29
US60126780 1999-03-29
PCT/IB2000/000431 WO2000058509A2 (en) 1999-03-29 2000-03-28 Prostate cancer associated human fibronectin gene and biallelic markers

Publications (1)

Publication Number Publication Date
AU4135600A true AU4135600A (en) 2000-10-16

Family

ID=22426617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41356/00A Abandoned AU4135600A (en) 1999-03-29 2000-03-28 Prostate cancer associated human fibronectin gene and biallelic markers

Country Status (2)

Country Link
AU (1) AU4135600A (en)
WO (1) WO2000058509A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008046510A1 (en) * 2006-10-16 2008-04-24 Bayer Healthcare Ag Fn1 as a biomarker, therapeutic and diagnostic target
KR101251538B1 (en) 2009-04-17 2013-04-08 (주)아벨리노 Primer for Avellino Corneal Dystrophy
KR101125212B1 (en) 2010-10-01 2012-03-21 (주)아벨리노 System for diagnosis of avellino corneal dystrophy
EP3486328B1 (en) 2013-03-15 2020-11-11 Avellino Lab USA, Inc. Methods for improved isolation of genomic dna templates for allele detection
US10889850B2 (en) 2013-03-15 2021-01-12 Avellino Lab Usa, Inc. Methods for improved isolation of genomic DNA templates for allele detection
JP6672147B2 (en) 2013-11-15 2020-03-25 アベリノ ラボ ユーエスエー インコーポレイテッドＡｖｅｌｌｉｎｏ Ｌａｂ ＵＳＡ， Ｉｎｃ． Multiplex detection method for alleles associated with eye diseases
WO2017083852A1 (en) 2015-11-13 2017-05-18 MOORE, Tara Methods for the treatment of corneal dystrophies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578444A (en) * 1991-06-27 1996-11-26 Genelabs Technologies, Inc. Sequence-directed DNA-binding molecules compositions and methods
EP0892068A1 (en) * 1997-07-18 1999-01-20 Genset Sa Method for generating a high density linkage disequilibrium-based map of the human genome

Also Published As

Publication number Publication date
WO2000058509A2 (en) 2000-10-05
WO2000058509A3 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
AU3619400A (en) Human prostate cancer associated gene sequences and polypeptides
AU2001278070A1 (en) Basal cell markers in breast cancer and uses thereof
AU3316600A (en) Gene expression in bladder tumors
AU1922301A (en) Differential gene expression in cancer
AUPQ923100A0 (en) Treatment of prostate cancer
AU2002360345A1 (en) Prostate cancer genes
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
AU2002356898A1 (en) Gene amplification and overexpression in cancer
AU4009899A (en) Molecules targeting cd40 and tumor cells
AU4135600A (en) Prostate cancer associated human fibronectin gene and biallelic markers
AU2238499A (en) Androgen-metabolic gene mutations and prostate cancer risk
AU8026300A (en) Sodd gene expression in cancer
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU2001226922A1 (en) Cancer associated genes and their products
GB9828840D0 (en) Prostate cancer associated genes and their products
AU2041901A (en) Genes essential for microbial proliferation and antisense thereto
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
AU1894601A (en) Novel gene and use thereof
GB0025890D0 (en) Gene therapy
AU4462600A (en) Novel prostate-restricted gene expressed in prostate cancer
AU5416700A (en) Differentially expressed genes in prostate cancer
AU2001290241A1 (en) Tumor cell proliferation inhibitors
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU2001288940A1 (en) Gene and sequence variation associated with cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase